FATT-CTL assay for detection of antigen-specific cell-mediated cytotoxicity

Cytometry Part A

Volumn 73, Issue 11, 2008, Pages 1058-1065

  Van Baalen, Carel A ^a   Gruters, Rob A ^a   Berkhoff, Eufemia G M ^a   Osterhaus, Albert D M E ^a   Rimmelzwaan, Guus F ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Antigen processing; Cell mediated immunity; Cytotoxicity tests; Human immunodeficiency virus; Immunologic; Influenza viruses

Indexed keywords

GREEN FLUORESCENT PROTEIN; NONSTRUCTURAL PROTEIN 1; PLASMID VECTOR; VIRUS PROTEIN; VIRUS VECTOR;

ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; CELL ASSAY; CELL IMMORTALIZATION; CELL MEDIATED CYTOTOXICITY; EX VIVO STUDY; FLOW CYTOMETRY; FLUORESCENT ANTIGEN TRANSFECTED TARGET CELL CYTOTOXIC T LYMPHOCYTE ASSAY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; IMMUNOTHERAPY; INFLUENZA VIRUS A; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN STRUCTURE; REVIEW;

ANTIGENS; CYTOTOXICITY, IMMUNOLOGIC; FLOW CYTOMETRY; HUMANS; INFLUENZA A VIRUS; REPRODUCIBILITY OF RESULTS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 55949096225     PISSN: 15524922     EISSN: 15524930     Source Type: Journal    
DOI: 10.1002/cyto.a.20613     Document Type: Review

References (33)

1. Brunner KT, Mauel J, Cerottini JC, Chapuis B. Quantitative assay of the lytic action of immune lymphoid cells on 51-Cr-labelled allogeneic target cells in vitro; inhibition by isoantibody and by drugs. Immunology 1968;14:181-196.
2. McMichael AJ, Gotch FM, Noble GR, Beare PA. Cytotoxic T-cell immunity to influenza. N Engl J Med 1983;309:13-17.
3. Bennink JR, Yewdell JW, Smith GL, Moller C, Moss B. Recombinant vaccinia virus primes and stimulates influenza haemagglutinin-specific cytotoxic T cells. Nature 1984;311:578-579.
4. Altman JD, Moss PA, Goulder PJ, Barouch DH, McHeyzer-Williams MG, Bell JI, McMichael AJ, Davis MM. Phenotypic analysis of antigen-specific T lymphocytes. Science 1996;274:94-96.
5. Chattopadhyay PK, Melenhorst JJ, Ladell KI, Gostick E, Scheinberg P, Barrett AJ, Wooldridge L, Roederer MR, Sewell AK, Price DA. Techniques to improve the direct ex vivo detection of low frequency antigen-specific CD8+ T cells with peptide-major histocompatibility complex class I tetramers. Cytometry A 2008;73A: in press. DOI: 10.1002/cyto.a.20642 (this issue).
6. Brooimans RA, Boyce CS, Popma J, Broyles DA, Gratama JW, Southwick PC, Keeney M. Analytical performance of a standardized single-platform MHC tetramer assay for the identification and enumeration of CMV-specific CD8+ T lymphocytes. Cytometry A 2008;73A: in press. DOI: 10.1002/cyto.a.20641 (this issue).
7. Wölfl M, Kuball J, Eyrich M, Schlegel PG, Greenberg PD. Use of CD137 to study the full repertoire of CD8+ T cells without the need to know epitope specificities. Cytometry A 2008;73A: in press. DOI: 10.1002/cyto.a.20594 (this issue).
8. Betts MR, Brenchley JM, Price DA, De Rosa SC, Douek DC, Roederer M, Koup RA. Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. J Immunol Methods 2003;281:65-78.
9. Miyahira Y, Murata K, Rodriguez D, Rodriguez JR, Esteban M, Rodrigues MM, Zavala F. Quantification of antigen specific CD8+ T cells using an ELISPOT assay. J Immunol Methods 1995;181:45-54.
10. Janetzki S, Cox JH, Oden N, Ferrari G. Standardization and validation issues of the ELISPOTassay. Methods Mol Biol 2005;302:51-86.
11. Mwau M, McMichael AJ, Hanke T. Design and validation of an enzyme-linked immunospot assay for use in clinical trials of candidate HIV vaccines. AIDS Res Hum Retroviruses 2002;18:611-618.
12. Olive D, Autran B, Robinet E. The ELISPOT assay - Quality issues related to its use in a multicenter setting. 2008; Presented at the third MASIR conference, La Plagne, France.
13. Maino VC, Picker LJ. Identification of functional subsets by flow cytometry: Intracellular detection of cytokine expression. Cytometry 1998;34:207-215.
14. Hural J, Horton H, Huang Y, McElrath MJ, De Rosa SC. Validation of intracellular cytokine staining assays for evaluation of T cell responses in vaccine trials. 2008; Presented at the third MASIR conference, La Plagne, France.
15. Nomura L, Maino V, Maecker HT. Standardization and optimization of multiparameter flow cytometric studies. Cytometry A 2008;73A: in press. DOI: 10.1002/cyto.a.20602 (this issue).
16. Hersperger AR, Makedonas G, Betts MR. Flow cytometric detection of perforin upregulation in human CD8 T cells. Cytometry A 2008;73A: in press. DOI: 10.1002/cyto.a.20596 (this issue).
17. Snyder JE, Bowers WJ, Livingstone AM, Lee FE, Federoff HJ, Mosmann TR. Measuring the frequency of mouse and human cytotoxic T cells by the Lysispot assay: Independent regulation of cytokine secretion and short-term killing. Nat Med 2003;9:231-235.
18. Snyder-Cappione JE, Divekar AA, Maupin GM, Jin X, Demeter LM, Mosmann TR. HIV-specific cytotoxic cell frequencies measured directly ex vivo by the Lysispot assay can be higher or lower than the frequencies of IFN-gamma-secreting cells: Anti-HIV cytotoxicity is not generally impaired relative to other chronic virus responses. J Immunol 2006;176:2662-2668.
19. Lecoeur H, Fevrier M, Garcia S, Riviere Y, Gougeon ML. A novel flow cytometric assay for quantitation and multiparametric characterization of cell-mediated cytotoxicity. J Immunol Methods 2001;253:177-187.
20. Lee-MacAry AE, Ross EL, Davies D, Laylor R, Honeychurch J, Glennie MJ, Snary D, Wilkinson RW. Development of a novel flow cytometric cell-mediated cytotoxicity assay using the fluorophores PKH-26 and TO-PRO-3 iodide. J Immunol Methods 2001;252:83-92.
21. Liu L, Chahroudi A, Silvestri G, Wernett ME, Kaiser WJ, Safrit JT, Komoriya A, Altman JD, Packard BZ, Feinberg MB. Visualization and quantification of T cell-mediated cytotoxicity using cell-permeable fluorogenic caspase substrates. Nat Med 2002;8:185-189.
22. Sheehy ME, McDermott AB, Furlan SN, Klenerman P, Nixon DF. A novel technique for the fluorometric assessment of T lymphocyte antigen specific lysis. J Immunol Methods 2001;249:99-110.
23. Van Baalen CA, Kwa D, Verschuren EJ, Reedijk ML, Boon AC, de Mutsert G, Rimmelzwaan GF, Osterhaus AD, Gruters RA. Fluorescent antigen-transfected target cell cytotoxic T lymphocyte assay for ex vivo detection of antigen-specific cell-mediated cytotoxicity. J Infect Dis 2005;192:1183-1190.
24. Berkhoff EG, Geelhoed-Mieras MM, Verschuren EJ, van Baalen CA, Gruters RA, Fouchier RA, Osterhaus AD, Rimmelzwaan GF. The loss of immunodominant epitopes affects interferon-gamma production and lytic activity of the human influenza virus-specific cytotoxic T lymphocyte response in vitro. Clin Exp Immunol 2007;148:296-306.
25. Landi A, Babiuk LA, van Drunen Littel-van den Hurk S. High transfection efficiency, gene expression, and viability of monocyte-derived human dendritic cells after nonviral gene transfer. J Leukoc Biol 2007;82:849-860.
26. Piguet V, Trono D. A structure-function analysis of the nef protein of primate lentiviruses. In: Kuiken CL, Foley B, Hahn B, Korber BT, McCutchan F, Marx PA, Mellors JW, Mullins JI, Sodroski J, Wolinksy S, editors. Human Retroviruses and AIDS 1999. Los Alamos, NM: Theoretical Biology and Biophysics Group, Los Alamos National Laboratory; 1999. pp 448-459.
27. Voeten JT, Bestebroer TM, Nieuwkoop NJ, Fouchier RA, Osterhaus AD, Rimmelzwaan GF. Antigenic drift in the influenza A virus (H3N2) nucleoprotein and escape from recognition by cytotoxic T lymphocytes. J Virol 2000;74:6800-6807.
28. Boon AC, de Mutsert G, Graus YM, Fouchier RA, Sintnicolaas K, Osterhaus AD, Rimmelzwaan GF. Sequence variation in a newly identified HLA-B35-restricted epitope in the influenza A virus nucleoprotein associated with escape from cytotoxic T lymphocytes. J Virol 2002;76:2567-2572.
29. Gog JR, Rimmelzwaan GF, Osterhaus AD, Grenfell BT. Population dynamics of rapid fixation in cytotoxic T lymphocyte escape mutants of influenza A. Proc Natl Acad Sci USA 2003;100:11143-11147.
30. Berkhoff EG, Boon AC, Nieuwkoop NJ, Fouchier RA, Sintnicolaas K, Osterhaus AD, Rimmelzwaan GF. A mutation in the HLA-B*2705-restricted NP383-391 epitope affects the human influenza A virus-specific cytotoxic T-lymphocyte response in vitro. J Virol 2004;78:5216-5222.
31. Rimmelzwaan GF, Boon AC, Voeten JT, Berkhoff EG, Fouchier RA, Osterhaus AD. Sequence variation in the influenza A virus nucleoprotein associated with escape from cytotoxic T lymphocytes. Virus Res 2004;103:97-100.
32. Boon AC, de Mutsert G, Fouchier RA, Osterhaus AD, Rimmelzwaan GF. The hypervariable immunodominant NP418-426 epitope from the influenza A virus nucleoprotein is recognized by cytotoxic T lymphocytes with high functional avidity. J Virol 2006;80:6024-6032.
33. Berkhoff EG, Geelhoed-Mieras MM, Fouchier RA, Osterhaus AD, Rimmelzwaan GF. Assessment of the extent of variation in influenza A virus cytotoxic T-lymphocyte epitopes by using virus-specific CD8+ T-cell clones. J Gen Virol 2007;88 (Part 2):530-535.